WPA
INSM icon

West Paces Advisors’s Insmed INSM Stock Holding History

West Paces Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Buy
+98
New +$11.9K ﹤0.01% 384

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

West Paces Advisors's INSM Position: Q2 2026 in Review

West Paces Advisors opened a new position in Insmed (INSM) in Q2 2026: 98 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #384 among its holdings.

663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • West Paces Advisors held 98 shares of Insmed worth $10.4K as of Q2 2026.
  • Insmed was a new West Paces Advisors position in Q2 2026.
  • Insmed made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #384 holding.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.